Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination

Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination

Background: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has caused over 6 million deaths world-wide. In the pre-vaccination era, we noted a 5·3% SARS-CoV-2 IgG antibody positivity rate in 81,624 subjects. Methods: Utilizing assays for serum SARS-CoV-2 spike (S) protein...

Full description

Bibliographic Details
Main Authors: Latha Dulipsingh, Maxine Lang, Margaret R. Diffenderfer, Lisa Cook, Jennifer Puff, Lynn Diaz, Lihong He, Ernst J. Schaefer
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Journal of Clinical Virology Plus
Subjects:
SARS-CoV 2
Pre booster and post booster serology
S protein antibodies
Neutralizing antibodies
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038022000692

Internet

http://www.sciencedirect.com/science/article/pii/S2667038022000692

Similar Items